{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T05:06:39Z","timestamp":1794978399672,"version":"4.9.1"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Biomed. Eng"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Protein glycosylation, a complex and heterogeneous post-translational modification that is frequently dysregulated in disease, has been difficult to analyse at scale. Here we report a data-independent acquisition technique for the large-scale mass-spectrometric quantification of glycopeptides in plasma samples. The technique, which we named \u2018OxoScan-MS\u2019, identifies oxonium ions as glycopeptide fragments and exploits a sliding-quadrupole dimension to generate comprehensive and untargeted oxonium ion maps of precursor masses assigned to fragment ions from non-enriched plasma samples. By applying OxoScan-MS to quantify 1,002 glycopeptide features in the plasma glycoproteomes from patients with COVID-19 and healthy controls, we found that severe COVID-19 induces differential glycosylation in IgA, haptoglobin, transferrin and other disease-relevant plasma glycoproteins. OxoScan-MS may allow for the quantitative mapping of glycoproteomes at the scale of hundreds to thousands of samples.<\/jats:p>","DOI":"10.1038\/s41551-023-01067-5","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T16:02:27Z","timestamp":1689868947000},"page":"233-247","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Oxonium ion scanning mass spectrometry for large-scale plasma glycoproteomics"],"prefix":"10.1038","volume":"8","author":[{"given":"Matthew E. H.","family":"White","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4692-0681","authenticated-orcid":false,"given":"Ludwig R.","family":"Sinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Marc","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9704-2925","authenticated-orcid":false,"given":"Joost","family":"de Folter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simran Kaur","family":"Aulakh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7002-9130","authenticated-orcid":false,"given":"Helen R.","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Kr\u00fcger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinkus","family":"Tober-Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadim","family":"Demichev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3807-473X","authenticated-orcid":false,"given":"Florian","family":"Kurth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9792-3861","authenticated-orcid":false,"given":"Michael","family":"M\u00fclleder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph B.","family":"Messner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9535-7413","authenticated-orcid":false,"given":"Markus","family":"Ralser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,20]]},"reference":[{"key":"1067_CR1","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1074\/mcp.R200007-MCP200","volume":"1","author":"NL Anderson","year":"2002","unstructured":"Anderson, N. L. & Anderson, N. G. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteom. 1, 845\u2013867 (2002).","journal-title":"Mol. Cell. Proteom."},{"key":"1067_CR2","doi-asserted-by":"crossref","first-page":"942","DOI":"10.15252\/msb.20156297","volume":"13","author":"PE Geyer","year":"2017","unstructured":"Geyer, P. E., Holdt, L. M., Teupser, D. & Mann, M. Revisiting biomarker discovery by plasma proteomics. Mol. Syst. Biol. 13, 942 (2017).","journal-title":"Mol. Syst. Biol."},{"key":"1067_CR3","doi-asserted-by":"publisher","unstructured":"Vernardis, S. I. et al. The impact of acute nutritional interventions on the plasma proteome. J. Clin. Endocrinol. Metab. https:\/\/doi.org\/10.1210\/clinem\/dgad031 (2023).","DOI":"10.1210\/clinem\/dgad031"},{"key":"1067_CR4","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/s41591-022-01850-y","volume":"28","author":"L Niu","year":"2022","unstructured":"Niu, L. et al. Noninvasive proteomic biomarkers for alcohol-related liver disease. Nat. Med. 28, 1277\u20131287 (2022).","journal-title":"Nat. Med."},{"key":"1067_CR5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cels.2020.05.012","volume":"11","author":"CB Messner","year":"2020","unstructured":"Messner, C. B. et al. Ultra-high-throughput clinical proteomics reveals classifiers of COVID-19 infection. Cell Syst. 11, 11\u201324.e4 (2020).","journal-title":"Cell Syst."},{"key":"1067_CR6","doi-asserted-by":"crossref","first-page":"e95192","DOI":"10.1371\/journal.pone.0095192","volume":"9","author":"E Assarsson","year":"2014","unstructured":"Assarsson, E. et al. Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS ONE 9, e95192 (2014).","journal-title":"PLoS ONE"},{"key":"1067_CR7","doi-asserted-by":"crossref","first-page":"e15004","DOI":"10.1371\/journal.pone.0015004","volume":"5","author":"L Gold","year":"2010","unstructured":"Gold, L. et al. Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS ONE 5, e15004 (2010).","journal-title":"PLoS ONE"},{"key":"1067_CR8","doi-asserted-by":"crossref","first-page":"eabj1541","DOI":"10.1126\/science.abj1541","volume":"374","author":"M Pietzner","year":"2021","unstructured":"Pietzner, M. et al. Mapping the proteo-genomic convergence of human diseases. Science 374, eabj1541 (2021).","journal-title":"Science"},{"key":"1067_CR9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nature19949","volume":"537","author":"R Aebersold","year":"2016","unstructured":"Aebersold, R. & Mann, M. Mass-spectrometric exploration of proteome structure and function. Nature 537, 347\u2013355 (2016).","journal-title":"Nature"},{"key":"1067_CR10","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.cca.2012.06.007","volume":"413","author":"T Vermassen","year":"2012","unstructured":"Vermassen, T., Speeckaert, M. M., Lumen, N., Rottey, S. & Delanghe, J. R. Glycosylation of prostate specific antigen and its potential diagnostic applications. Clin. Chim. Acta 413, 1500\u20131505 (2012).","journal-title":"Clin. Chim. Acta"},{"key":"1067_CR11","doi-asserted-by":"crossref","first-page":"608466","DOI":"10.3389\/fimmu.2020.608466","volume":"11","author":"T \u010caval","year":"2020","unstructured":"\u010caval, T. et al. Glycoproteoform profiles of individual patients\u2019 plasma alpha-1-antichymotrypsin are unique and extensively remodeled following a septic episode. Front. Immunol. 11, 608466 (2020).","journal-title":"Front. Immunol."},{"key":"1067_CR12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/138920307779941497","volume":"8","author":"F Ceciliani","year":"2007","unstructured":"Ceciliani, F. & Pocacqua, V. The acute phase protein alpha1-acid glycoprotein: a model for altered glycosylation during diseases. Curr. Protein Pept. Sci. 8, 91\u2013108 (2007).","journal-title":"Curr. Protein Pept. Sci."},{"key":"1067_CR13","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3390\/v14030553","volume":"14","author":"C Pickering","year":"2022","unstructured":"Pickering, C. et al. Differential peripheral blood glycoprotein profiles in symptomatic and asymptomatic COVID-19. Viruses 14, 553 (2022).","journal-title":"Viruses"},{"key":"1067_CR14","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41581-019-0129-4","volume":"15","author":"C Reily","year":"2019","unstructured":"Reily, C., Stewart, T. J., Renfrow, M. B. & Novak, J. Glycosylation in health and disease. Nat. Rev. Nephrol. 15, 346\u2013366 (2019).","journal-title":"Nat. Rev. Nephrol."},{"key":"1067_CR15","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1074\/mcp.O113.034181","volume":"12","author":"JV Olsen","year":"2013","unstructured":"Olsen, J. V. & Mann, M. Status of large-scale analysis of post-translational modifications by mass spectrometry. Mol. Cell. Proteom. 12, 3444\u20133452 (2013).","journal-title":"Mol. Cell. Proteom."},{"key":"1067_CR16","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-25454-1","volume":"12","author":"M Steger","year":"2021","unstructured":"Steger, M. et al. Time-resolved in vivo ubiquitinome profiling by DIA-MS reveals USP7 targets on a proteome-wide scale. Nat. Commun. 12, 5399 (2021).","journal-title":"Nat. Commun."},{"key":"1067_CR17","volume":"11","author":"DB Bekker-Jensen","year":"2020","unstructured":"Bekker-Jensen, D. B. et al. Rapid and site-specific deep phosphoproteome profiling by data-independent acquisition without the need for spectral libraries. Nat. Commun. 11, 787 (2020).","journal-title":"Nat. Commun."},{"key":"1067_CR18","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/s41592-019-0504-x","volume":"16","author":"Z Ye","year":"2019","unstructured":"Ye, Z., Mao, Y., Clausen, H. & Vakhrushev, S. Y. Glyco-DIA: a method for quantitative O-glycoproteomics with in silico-boosted glycopeptide libraries. Nat. Methods 16, 902\u2013910 (2019).","journal-title":"Nat. Methods"},{"key":"1067_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10719-021-09973-z","volume":"38","author":"Y-L Wong","year":"2021","unstructured":"Wong, Y.-L. et al. Identification of potential glycoprotein biomarkers in oral squamous cell carcinoma using sweet strategies. Glycoconj. J. 38, 1\u201311 (2021).","journal-title":"Glycoconj. J."},{"key":"1067_CR20","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.bbagen.2018.03.025","volume":"1862","author":"Y Miura","year":"2018","unstructured":"Miura, Y. et al. Characteristic glycopeptides associated with extreme human longevity identified through plasma glycoproteomics. Biochim. Biophys. Acta Gen. Subj. 1862, 1462\u20131471 (2018).","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"1067_CR21","doi-asserted-by":"publisher","unstructured":"Messner, C. B. et al. Ultra-fast proteomics with Scanning SWATH. Nat. Biotechnol. https:\/\/doi.org\/10.1038\/s41587-021-00860-4 (2021)","DOI":"10.1038\/s41587-021-00860-4"},{"key":"1067_CR22","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/s41592-020-00998-0","volume":"17","author":"F Meier","year":"2020","unstructured":"Meier, F. et al. diaPASEF: parallel accumulation-serial fragmentation combined with data-independent acquisition. Nat. Methods 17, 1229\u20131236 (2020).","journal-title":"Nat. Methods"},{"key":"1067_CR23","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1038\/s41591-019-0673-2","volume":"25","author":"B Lehallier","year":"2019","unstructured":"Lehallier, B. et al. Undulating changes in human plasma proteome profiles across the lifespan. Nat. Med. 25, 1843\u20131850 (2019).","journal-title":"Nat. Med."},{"key":"1067_CR24","doi-asserted-by":"publisher","unstructured":"Muenzner, J. et al. The natural diversity of the yeast proteome reveals chromosome-wide dosage compensation in aneuploids. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2022.04.06.487392 (2022).","DOI":"10.1101\/2022.04.06.487392"},{"key":"1067_CR25","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10719-015-9641-3","volume":"33","author":"LF Zacchi","year":"2016","unstructured":"Zacchi, L. F. & Schulz, B. L. N-glycoprotein macroheterogeneity: biological implications and proteomic characterization. Glycoconj. J. 33, 359\u2013376 (2016).","journal-title":"Glycoconj. J."},{"key":"1067_CR26","doi-asserted-by":"crossref","first-page":"100010","DOI":"10.1074\/mcp.R120.002093","volume":"20","author":"T \u010caval","year":"2021","unstructured":"\u010caval, T., Heck, A. J. R. & Reiding, K. R. Meta-heterogeneity: evaluating and describing the diversity in glycosylation between sites on the same glycoprotein. Mol. Cell. Proteom. 20, 100010 (2021).","journal-title":"Mol. Cell. Proteom."},{"key":"1067_CR27","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.4155\/bio-2017-0214","volume":"9","author":"W Zhou","year":"2017","unstructured":"Zhou, W., Yang, S. & Wang, P. G. Matrix effects and application of matrix effect factor. Bioanalysis 9, 1839\u20131844 (2017).","journal-title":"Bioanalysis"},{"key":"1067_CR28","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/jms.3210","volume":"48","author":"K Stavenhagen","year":"2013","unstructured":"Stavenhagen, K. et al. Quantitative mapping of glycoprotein micro-heterogeneity and macro-heterogeneity: an evaluation of mass spectrometry signal strengths using synthetic peptides and glycopeptides. J. Mass Spectrom. 48, 627\u2013639 (2013).","journal-title":"J. Mass Spectrom."},{"key":"1067_CR29","doi-asserted-by":"crossref","first-page":"100029","DOI":"10.1074\/mcp.R120.002277","volume":"20","author":"NM Riley","year":"2021","unstructured":"Riley, N. M., Bertozzi, C. R. & Pitteri, S. J. A pragmatic guide to enrichment strategies for mass spectrometry-based glycoproteomics. Mol. Cell. Proteom. 20, 100029 (2021).","journal-title":"Mol. Cell. Proteom."},{"key":"1067_CR30","volume":"11","author":"P Fang","year":"2020","unstructured":"Fang, P. et al. A streamlined pipeline for multiplexed quantitative site-specific N-glycoproteomics. Nat. Commun. 11, 5268 (2020).","journal-title":"Nat. Commun."},{"key":"1067_CR31","doi-asserted-by":"crossref","first-page":"O111.016717","DOI":"10.1074\/mcp.O111.016717","volume":"11","author":"LC Gillet","year":"2012","unstructured":"Gillet, L. C. et al. Targeted data extraction of the MS\/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis. Mol. Cell. Proteom. 11, O111.016717 (2012).","journal-title":"Mol. Cell. Proteom."},{"key":"1067_CR32","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1074\/mcp.RA117.000314","volume":"16","author":"R Bruderer","year":"2017","unstructured":"Bruderer, R. et al. Optimization of experimental parameters in data-independent mass spectrometry significantly increases depth and reproducibility of results. Mol. Cell. Proteom. 16, 2296\u20132309 (2017).","journal-title":"Mol. Cell. Proteom."},{"key":"1067_CR33","doi-asserted-by":"crossref","first-page":"e8126","DOI":"10.15252\/msb.20178126","volume":"14","author":"C Ludwig","year":"2018","unstructured":"Ludwig, C. et al. Data-independent acquisition-based SWATH-MS for quantitative proteomics: a tutorial. Mol. Syst. Biol. 14, e8126 (2018).","journal-title":"Mol. Syst. Biol."},{"key":"1067_CR34","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41592-019-0638-x","volume":"17","author":"V Demichev","year":"2020","unstructured":"Demichev, V., Messner, C. B., Vernardis, S. I., Lilley, K. S. & Ralser, M. DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput. Nat. Methods 17, 41\u201344 (2020).","journal-title":"Nat. Methods"},{"key":"1067_CR35","doi-asserted-by":"crossref","first-page":"100042","DOI":"10.1074\/mcp.R120.002204","volume":"20","author":"Z Ye","year":"2021","unstructured":"Ye, Z. & Vakhrushev, S. Y. The role of data-independent acquisition for glycoproteomics. Mol. Cell. Proteom. 20, 100042 (2021).","journal-title":"Mol. Cell. Proteom."},{"key":"1067_CR36","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1016\/j.celrep.2018.04.114","volume":"23","author":"T Sajic","year":"2018","unstructured":"Sajic, T. et al. Similarities and differences of blood N-glycoproteins in five solid carcinomas at localized clinical stage analyzed by SWATH-MS. Cell Rep. 23, 2819\u20132831.e5 (2018).","journal-title":"Cell Rep."},{"key":"1067_CR37","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1074\/mcp.M114.038273","volume":"13","author":"Y Liu","year":"2014","unstructured":"Liu, Y. et al. Glycoproteomic analysis of prostate cancer tissues by SWATH mass spectrometry discovers N-acylethanolamine acid amidase and protein tyrosine kinase 7 as signatures for tumor aggressiveness. Mol. Cell. Proteom. 13, 1753\u20131768 (2014).","journal-title":"Mol. Cell. Proteom."},{"key":"1067_CR38","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1074\/mcp.M400090-MCP200","volume":"4","author":"H Zhang","year":"2005","unstructured":"Zhang, H. et al. High throughput quantitative analysis of serum proteins using glycopeptide capture and liquid chromatography mass spectrometry. Mol. Cell. Proteom. 4, 144\u2013155 (2005).","journal-title":"Mol. Cell. Proteom."},{"key":"1067_CR39","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1002\/pmic.201400465","volume":"15","author":"Y Xu","year":"2015","unstructured":"Xu, Y., Bailey, U.-M. & Schulz, B. L. Automated measurement of site-specific N-glycosylation occupancy with SWATH-MS. Proteomics 15, 2177\u20132186 (2015).","journal-title":"Proteomics"},{"key":"1067_CR40","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1039\/C9MO00125E","volume":"16","author":"TK Phung","year":"2020","unstructured":"Phung, T. K., Zacchi, L. F. & Schulz, B. L. DIALib: an automated ion library generator for data independent acquisition mass spectrometry analysis of peptides and glycopeptides. Mol. Omics 16, 100\u2013112 (2020).","journal-title":"Mol. Omics"},{"key":"1067_CR41","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00216-016-0041-8","volume":"409","author":"M Sanda","year":"2017","unstructured":"Sanda, M., Zhang, L., Edwards, N. J. & Goldman, R. Site-specific analysis of changes in the glycosylation of proteins in liver cirrhosis using data-independent workflow with soft fragmentation. Anal. Bioanal. Chem. 409, 619\u2013627 (2017).","journal-title":"Anal. Bioanal. Chem."},{"key":"1067_CR42","doi-asserted-by":"crossref","first-page":"10118","DOI":"10.1021\/acs.analchem.6b02554","volume":"88","author":"M Sanda","year":"2016","unstructured":"Sanda, M. & Goldman, R. Data independent analysis of IgG glycoforms in samples of unfractionated human plasma. Anal. Chem. 88, 10118\u201310125 (2016).","journal-title":"Anal. Chem."},{"key":"1067_CR43","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1074\/mcp.M115.056366","volume":"15","author":"LF Zacchi","year":"2016","unstructured":"Zacchi, L. F. & Schulz, B. L. SWATH-MS glycoproteomics reveals consequences of defects in the glycosylation machinery. Mol. Cell. Proteom. 15, 2435\u20132447 (2016).","journal-title":"Mol. Cell. Proteom."},{"key":"1067_CR44","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1021\/acs.analchem.6b04996","volume":"89","author":"K-T Pan","year":"2017","unstructured":"Pan, K.-T., Chen, C.-C., Urlaub, H. & Khoo, K.-H. Adapting data-independent acquisition for mass spectrometry-based protein site-specific N-glycosylation analysis. Anal. Chem. 89, 4532\u20134539 (2017).","journal-title":"Anal. Chem."},{"key":"1067_CR45","doi-asserted-by":"crossref","first-page":"6073","DOI":"10.1038\/s41467-021-26246-3","volume":"12","author":"Y Yang","year":"2021","unstructured":"Yang, Y. et al. GproDIA enables data-independent acquisition glycoproteomics with comprehensive statistical control. Nat. Commun. 12, 6073 (2021).","journal-title":"Nat. Commun."},{"key":"1067_CR46","doi-asserted-by":"crossref","first-page":"13774","DOI":"10.1021\/acs.analchem.1c01659","volume":"93","author":"M Dong","year":"2021","unstructured":"Dong, M. et al. Data-independent acquisition-based mass spectrometry (DIA-MS) for quantitative analysis of intact N-linked glycopeptides. Anal. Chem. 93, 13774\u201313782 (2021).","journal-title":"Anal. Chem."},{"key":"1067_CR47","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1074\/mcp.RA119.001791","volume":"19","author":"Q Shu","year":"2020","unstructured":"Shu, Q. et al. Large-scale identification of N-linked intact glycopeptides in human serum using HILIC enrichment and spectral library search. Mol. Cell. Proteom. 19, 672\u2013689 (2020).","journal-title":"Mol. Cell. Proteom."},{"key":"1067_CR48","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-09222-w","volume":"10","author":"NM Riley","year":"2019","unstructured":"Riley, N. M., Hebert, A. S., Westphall, M. S. & Coon, J. J. Capturing site-specific heterogeneity with large-scale N-glycoproteome analysis. Nat. Commun. 10, 1311 (2019).","journal-title":"Nat. Commun."},{"key":"1067_CR49","doi-asserted-by":"crossref","first-page":"100081","DOI":"10.1016\/j.mcpro.2021.100081","volume":"20","author":"Z Chen","year":"2021","unstructured":"Chen, Z. et al. In-depth site-specific analysis of N-glycoproteome in human cerebrospinal fluid and glycosylation landscape changes in Alzheimer\u2019s disease. Mol. Cell. Proteom. 20, 100081 (2021).","journal-title":"Mol. Cell. Proteom."},{"key":"1067_CR50","doi-asserted-by":"crossref","DOI":"10.1038\/srep37189","volume":"6","author":"S Toghi Eshghi","year":"2016","unstructured":"Toghi Eshghi, S. et al. Classification of tandem mass spectra for identification of N- and O-linked glycopeptides. Sci. Rep. 6, 37189 (2016).","journal-title":"Sci. Rep."},{"key":"1067_CR51","doi-asserted-by":"crossref","first-page":"6024","DOI":"10.1021\/pr500898r","volume":"13","author":"A Halim","year":"2014","unstructured":"Halim, A. et al. Assignment of saccharide identities through analysis of oxonium ion fragmentation profiles in LC\u2013MS\/MS of glycopeptides. J. Proteome Res. 13, 6024\u20136032 (2014).","journal-title":"J. Proteome Res."},{"key":"1067_CR52","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/chem.201503659","volume":"22","author":"J Yu","year":"2016","unstructured":"Yu, J. et al. Distinctive MS\/MS fragmentation pathways of glycopeptide-generated oxonium ions provide evidence of the glycan structure. Chemistry 22, 1114\u20131124 (2016).","journal-title":"Chemistry"},{"key":"1067_CR53","first-page":"968","volume":"10","author":"JA Madsen","year":"2018","unstructured":"Madsen, J. A., Farutin, V., Lin, Y. Y., Smith, S. & Capila, I. Data-independent oxonium ion profiling of multi-glycosylated biotherapeutics. MAbs 10, 968\u2013978 (2018).","journal-title":"MAbs"},{"key":"1067_CR54","doi-asserted-by":"crossref","first-page":"e0195006","DOI":"10.1371\/journal.pone.0195006","volume":"13","author":"S Joenvaara","year":"2018","unstructured":"Joenvaara, S. et al. Quantitative N-glycoproteomics reveals altered glycosylation levels of various plasma proteins in bloodstream infected patients. PLoS ONE 13, e0195006 (2018).","journal-title":"PLoS ONE"},{"key":"1067_CR55","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/rcm.8016","volume":"32","author":"N Couto","year":"2018","unstructured":"Couto, N., Davlyatova, L., Evans, C. A. & Wright, P. C. Application of the broadband collision-induced dissociation (bbCID) mass spectrometry approach for protein glycosylation and phosphorylation analysis. Rapid Commun. Mass Spectrom. 32, 75\u201385 (2018).","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"1067_CR56","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S1044-0305(02)00421-X","volume":"13","author":"MA Ritchie","year":"2002","unstructured":"Ritchie, M. A., Gill, A. C., Deery, M. J. & Lilley, K. Precursor ion scanning for detection and structural characterization of heterogeneous glycopeptide mixtures. J. Am. Soc. Mass Spectrom. 13, 1065\u20131077 (2002).","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"1067_CR57","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S1044-0305(03)00263-0","volume":"14","author":"J Jebanathirajah","year":"2003","unstructured":"Jebanathirajah, J., Steen, H. & Roepstorff, P. Using optimized collision energies and high resolution, high accuracy fragment ion selection to improve glycopeptide detection by precursor ion scanning. J. Am. Soc. Mass Spectrom. 14, 777\u2013784 (2003).","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"1067_CR58","unstructured":"Gethings, L. A. et al. Glycopeptide fragmentation optimisation and quantitation by multi collision energy ramp scanning quadrupole DIA. Poster Presented at HUPO 2018 (Human Proteome Organization, 2018); https:\/\/www.waters.com\/webassets\/cms\/library\/docs\/2018hupo_geethings_glycopeptide_fragmentation.pdf"},{"key":"1067_CR59","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jproteome.7b00464","volume":"17","author":"MA Moseley","year":"2018","unstructured":"Moseley, M. A. et al. Scanning quadrupole data-independent acquisition, part A: qualitative and quantitative characterization. J. Proteome Res. 17, 770\u2013779 (2018).","journal-title":"J. Proteome Res."},{"key":"1067_CR60","doi-asserted-by":"crossref","first-page":"100486","DOI":"10.1016\/j.mcpro.2022.100486","volume":"22","author":"S Mukherjee","year":"2022","unstructured":"Mukherjee, S. et al. Oxonium ion-guided optimization of ion mobility-assisted glycoproteomics on the timsTOF Pro. Mol. Cell. Proteom. 22, 100486 (2022).","journal-title":"Mol. Cell. Proteom."},{"key":"1067_CR61","doi-asserted-by":"publisher","unstructured":"Wessels, H. J. et al. Plasma glycoproteomics delivers high-specificity disease biomarkers by detecting site-specific glycosylation abnormalities. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2022.05.31.494121 (2022).","DOI":"10.1101\/2022.05.31.494121"},{"key":"1067_CR62","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3389\/fimmu.2020.00654","volume":"11","author":"M Wieczorek","year":"2020","unstructured":"Wieczorek, M., Braicu, E. I., Oliveira-Ferrer, L., Sehouli, J. & Blanchard, V. Immunoglobulin G subclass-specific glycosylation changes in primary epithelial ovarian cancer. Front. Immunol. 11, 654 (2020).","journal-title":"Front. Immunol."},{"key":"1067_CR63","doi-asserted-by":"crossref","first-page":"4518","DOI":"10.1021\/acs.analchem.9b05722","volume":"92","author":"A Mom\u010dilovi\u0107","year":"2020","unstructured":"Mom\u010dilovi\u0107, A. et al. Simultaneous immunoglobulin A and G glycopeptide profiling for high-throughput applications. Anal. Chem. 92, 4518\u20134526 (2020).","journal-title":"Anal. Chem."},{"key":"1067_CR64","doi-asserted-by":"crossref","first-page":"13360","DOI":"10.1021\/acs.analchem.9b02584","volume":"91","author":"E Ang","year":"2019","unstructured":"Ang, E., Neustaeter, H., Spicer, V., Perreault, H. & Krokhin, O. Retention time prediction for glycopeptides in reversed-phase chromatography for glycoproteomic applications. Anal. Chem. 91, 13360\u201313366 (2019).","journal-title":"Anal. Chem."},{"key":"1067_CR65","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1074\/mcp.RA118.001185","volume":"18","author":"KB Chandler","year":"2019","unstructured":"Chandler, K. B. et al. Multi-isotype glycoproteomic characterization of serum antibody heavy chains reveals isotype- and subclass-specific N-glycosylation profiles. Mol. Cell. Proteom. 18, 686\u2013703 (2019).","journal-title":"Mol. Cell. Proteom."},{"key":"1067_CR66","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jprot.2017.10.011","volume":"172","author":"C-H Lin","year":"2018","unstructured":"Lin, C.-H., Krisp, C., Packer, N. H. & Molloy, M. P. Development of a data independent acquisition mass spectrometry workflow to enable glycopeptide analysis without predefined glycan compositional knowledge. J. Proteom. 172, 68\u201375 (2018).","journal-title":"J. Proteom."},{"key":"1067_CR67","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10719-015-9626-2","volume":"33","author":"F Clerc","year":"2016","unstructured":"Clerc, F. et al. Human plasma protein N-glycosylation. Glycoconj. J. 33, 309\u2013343 (2016).","journal-title":"Glycoconj. J."},{"key":"1067_CR68","doi-asserted-by":"crossref","unstructured":"Huber, S. in Data Science \u2013 Analytics and Applications 81\u201388 (Springer, 2021).","DOI":"10.1007\/978-3-658-32182-6_13"},{"key":"1067_CR69","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3233\/IDA-2007-11508","volume":"11","author":"S Salvador","year":"2007","unstructured":"Salvador, S. & Chan, P. Toward accurate dynamic time warping in linear time and space. Intell. Data Anal. 11, 561\u2013580 (2007).","journal-title":"Intell. Data Anal."},{"key":"1067_CR70","doi-asserted-by":"crossref","first-page":"e0000007","DOI":"10.1371\/journal.pdig.0000007","volume":"1","author":"V Demichev","year":"2022","unstructured":"Demichev, V. et al. A proteomic survival predictor for COVID-19 patients in intensive care. PLOS Digit. Health 1, e0000007 (2022).","journal-title":"PLOS Digit. Health"},{"key":"1067_CR71","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/s41592-021-01309-x","volume":"18","author":"R Kawahara","year":"2021","unstructured":"Kawahara, R. et al. Community evaluation of glycoproteomics informatics solutions reveals high-performance search strategies for serum glycopeptide analysis. Nat. Methods 18, 1304\u20131316 (2021).","journal-title":"Nat. Methods"},{"key":"1067_CR72","doi-asserted-by":"publisher","unstructured":"Bern, M., Kil, Y. J. & Becker, C. Byonic: advanced peptide and protein identification software. Curr. Protoc. Bioinformatics https:\/\/doi.org\/10.1002\/0471250953.bi1320s40 (2012).","DOI":"10.1002\/0471250953.bi1320s40"},{"key":"1067_CR73","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/s41592-020-0967-9","volume":"17","author":"DA Polasky","year":"2020","unstructured":"Polasky, D. A., Yu, F., Teo, G. C. & Nesvizhskii, A. I. Fast and comprehensive N- and O-glycoproteomics analysis with MSFragger-Glyco. Nat. Methods 17, 1125\u20131132 (2020).","journal-title":"Nat. Methods"},{"key":"1067_CR74","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1021\/acs.jproteome.0c00602","volume":"20","author":"M Dermit","year":"2021","unstructured":"Dermit, M., Peters-Clarke, T. M., Shishkova, E. & Meyer, J. G. Peptide correlation analysis (PeCorA) reveals differential proteoform regulation. J. Proteome Res. 20, 1972\u20131980 (2021).","journal-title":"J. Proteome Res."},{"key":"1067_CR75","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.bbrc.2014.04.107","volume":"448","author":"T Yoneyama","year":"2014","unstructured":"Yoneyama, T. et al. Measurement of aberrant glycosylation of prostate specific antigen can improve specificity in early detection of prostate cancer. Biochem. Biophys. Res. Commun. 448, 390\u2013396 (2014).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1067_CR76","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/jnr.24805","volume":"99","author":"M-M Xu","year":"2021","unstructured":"Xu, M.-M., Zhou, M.-T., Li, S.-W., Zhen, X.-C. & Yang, S. Glycoproteins as diagnostic and prognostic biomarkers for neurodegenerative diseases: a glycoproteomic approach. J. Neurosci. Res. 99, 1308\u20131324 (2021).","journal-title":"J. Neurosci. Res."},{"key":"1067_CR77","doi-asserted-by":"crossref","first-page":"11848","DOI":"10.1073\/pnas.1102664108","volume":"108","author":"A Halim","year":"2011","unstructured":"Halim, A. et al. Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein\/amyloid beta-peptides in human cerebrospinal fluid. Proc. Natl Acad. Sci. USA 108, 11848\u201311853 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1067_CR78","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.cels.2021.05.005","volume":"12","author":"V Demichev","year":"2021","unstructured":"Demichev, V. et al. A time-resolved proteomic and prognostic map of COVID-19. Cell Syst. 12, 780\u2013794.e7 (2021).","journal-title":"Cell Syst."},{"key":"1067_CR79","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2020.05.032","volume":"182","author":"B Shen","year":"2020","unstructured":"Shen, B. et al. Proteomic and metabolomic characterization of COVID-19 patient sera. Cell 182, 59\u201372.e15 (2020).","journal-title":"Cell"},{"key":"1067_CR80","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1042\/BST20200222","volume":"49","author":"A Chernykh","year":"2021","unstructured":"Chernykh, A., Kawahara, R. & Thaysen-Andersen, M. Towards structure-focused glycoproteomics. Biochem. Soc. Trans. 49, 161\u2013186 (2021).","journal-title":"Biochem. Soc. Trans."},{"key":"1067_CR81","doi-asserted-by":"crossref","first-page":"9320","DOI":"10.1002\/anie.201803540","volume":"57","author":"C Pett","year":"2018","unstructured":"Pett, C. et al. Effective assignment of \u03b12,3\/\u03b12,6-sialic acid isomers by LC\u2013MS\/MS-based glycoproteomics. Angew. Chem. Int. Ed. Engl. 57, 9320\u20139324 (2018).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"1067_CR82","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10549-019-05258-0","volume":"176","author":"EN Cohen","year":"2019","unstructured":"Cohen, E. N. et al. Elevated serum levels of sialyl Lewis X (sLeX) and inflammatory mediators in patients with breast cancer. Breast Cancer Res. Treat. 176, 545\u2013556 (2019).","journal-title":"Breast Cancer Res. Treat."},{"key":"1067_CR83","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41573-020-00093-1","volume":"20","author":"BAH Smith","year":"2021","unstructured":"Smith, B. A. H. & Bertozzi, C. R. The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans. Nat. Rev. Drug Discov. 20, 217\u2013243 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1067_CR84","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1146\/annurev-pathol-012414-040438","volume":"10","author":"SR Stowell","year":"2015","unstructured":"Stowell, S. R., Ju, T. & Cummings, R. D. Protein glycosylation in cancer. Annu. Rev. Pathol. 10, 473\u2013510 (2015).","journal-title":"Annu. Rev. Pathol."},{"key":"1067_CR85","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1021\/acs.jproteome.6b00487","volume":"16","author":"RA Everley","year":"2017","unstructured":"Everley, R. A., Huttlin, E. L., Erickson, A. R., Beausoleil, S. A. & Gygi, S. P. Neutral loss is a very common occurrence in phosphotyrosine-containing peptides labeled with isobaric tags. J. Proteome Res. 16, 1069\u20131076 (2017).","journal-title":"J. Proteome Res."},{"key":"1067_CR86","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1074\/mcp.O113.035915","volume":"13","author":"CD Kelstrup","year":"2014","unstructured":"Kelstrup, C. D., Frese, C., Heck, A. J. R., Olsen, J. V. & Nielsen, M. L. Analytical utility of mass spectral binning in proteomic experiments by SPectral Immonium Ion Detection (SPIID). Mol. Cell. Proteom. 13, 1914\u20131924 (2014).","journal-title":"Mol. Cell. Proteom."},{"key":"1067_CR87","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1021\/jasms.1c00084","volume":"32","author":"B Calle","year":"2021","unstructured":"Calle, B. et al. Benefits of chemical sugar modifications introduced by click chemistry for glycoproteomic analyses. J. Am. Soc. Mass Spectrom. 32, 2366\u20132375 (2021).","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"1067_CR88","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1007\/s00216-019-01657-w","volume":"411","author":"M Lettow","year":"2019","unstructured":"Lettow, M. et al. The role of the mobile proton in fucose migration. Anal. Bioanal. Chem. 411, 4637\u20134645 (2019).","journal-title":"Anal. Bioanal. Chem."},{"key":"1067_CR89","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s15010-020-01464-x","volume":"48","author":"F Kurth","year":"2020","unstructured":"Kurth, F. et al. Studying the pathophysiology of coronavirus disease 2019: a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19). Infection 48, 619\u2013626 (2020).","journal-title":"Infection"},{"key":"1067_CR90","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","volume":"26","author":"B MacLean","year":"2010","unstructured":"MacLean, B. et al. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 26, 966\u2013968 (2010).","journal-title":"Bioinformatics"},{"key":"1067_CR91","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.21105\/joss.01686","volume":"4","author":"H Wickham","year":"2019","unstructured":"Wickham, H. et al. Welcome to the tidyverse. J. Open Source Softw. 4, 1686 (2019).","journal-title":"J. Open Source Softw."},{"key":"1067_CR92","doi-asserted-by":"crossref","unstructured":"Wickham, H. ggplot2 (Springer, 2009).","DOI":"10.1007\/978-0-387-98141-3"},{"key":"1067_CR93","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"1067_CR94","doi-asserted-by":"crossref","unstructured":"Millard, S. P. EnvStats (Springer, 2013).","DOI":"10.1007\/978-1-4614-8456-1"},{"key":"1067_CR95","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu, Z., Eils, R. & Schlesner, M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32, 2847\u20132849 (2016).","journal-title":"Bioinformatics"},{"key":"1067_CR96","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1021\/acs.jproteome.6b00438","volume":"15","author":"LY Lee","year":"2016","unstructured":"Lee, L. Y. et al. Toward automated N-glycopeptide identification in glycoproteomics. J. Proteome Res. 15, 3904\u20133915 (2016).","journal-title":"J. Proteome Res."},{"key":"1067_CR97","doi-asserted-by":"publisher","unstructured":"White, M. et al. Dataset for \u2018Oxonium ion scanning mass spectrometry for large-scale plasma glycoproteomics\u2019. Figshare https:\/\/doi.org\/10.6084\/m9.figshare.c.6677135.v1 (2023).","DOI":"10.6084\/m9.figshare.c.6677135.v1"},{"key":"1067_CR98","doi-asserted-by":"publisher","unstructured":"White. M. et al. Dataset and custom code for \u2018Oxonium ion scanning mass spectrometry for large-scale plasma glycoproteomics\u2019. Zenodo https:\/\/doi.org\/10.5281\/zenodo.8015483 (2023).","DOI":"10.5281\/zenodo.8015483"},{"key":"1067_CR99","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc. B"}],"container-title":["Nature Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41551-023-01067-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-023-01067-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-023-01067-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T18:44:25Z","timestamp":1729795465000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41551-023-01067-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,20]]},"references-count":99,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["1067"],"URL":"https:\/\/doi.org\/10.1038\/s41551-023-01067-5","relation":{},"ISSN":["2157-846X"],"issn-type":[{"value":"2157-846X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,20]]},"assertion":[{"value":"19 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.R. is founder and shareholder of Eliptica Ltd.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}